Correlation of Overall Survival With Clinical and Biologic Features of 103 Patients With AML
| Clinical Factor (no.) . | Log-Rank (P) . | g-Wilcoxon (P) . |
|---|---|---|
| Age (yr) | ||
| ≤50 (50) | ||
| >50 (53) | .005 | <.001 |
| Sex | ||
| M (63) | ||
| F (40) | NS | NS |
| WBC (×109/L) | ||
| ≤50 (74) | ||
| >50 (28) | .004 | <.001 |
| LDH | ||
| ≥N, ≤5 × N (87) | ||
| >5 × N (14) | .003 | <.001 |
| CD7 | ||
| Negative (67) | ||
| Positive (17) | NS | NS |
| Chromosomal aberration | ||
| − (40) | ||
| + (61) | NS | NS |
| − (40) | ||
| t(8;21) (13) | .041 | NS |
| t(15;17) (14) | <.005 | <.005 |
| inv(16) (3) | NS | NS |
| 11q23 (3) | NS | NS |
| MAKA (5) | NS | NS |
| Others (24) | NS | NS |
| nm23-H1 Index | ||
| ≤100 (71) | ||
| >100 (32) | <.001 | <.005 |
| nm23-H2 Index | ||
| ≤110 (77) | ||
| >110 (26) | NS | <.05 |
| Clinical Factor (no.) . | Log-Rank (P) . | g-Wilcoxon (P) . |
|---|---|---|
| Age (yr) | ||
| ≤50 (50) | ||
| >50 (53) | .005 | <.001 |
| Sex | ||
| M (63) | ||
| F (40) | NS | NS |
| WBC (×109/L) | ||
| ≤50 (74) | ||
| >50 (28) | .004 | <.001 |
| LDH | ||
| ≥N, ≤5 × N (87) | ||
| >5 × N (14) | .003 | <.001 |
| CD7 | ||
| Negative (67) | ||
| Positive (17) | NS | NS |
| Chromosomal aberration | ||
| − (40) | ||
| + (61) | NS | NS |
| − (40) | ||
| t(8;21) (13) | .041 | NS |
| t(15;17) (14) | <.005 | <.005 |
| inv(16) (3) | NS | NS |
| 11q23 (3) | NS | NS |
| MAKA (5) | NS | NS |
| Others (24) | NS | NS |
| nm23-H1 Index | ||
| ≤100 (71) | ||
| >100 (32) | <.001 | <.005 |
| nm23-H2 Index | ||
| ≤110 (77) | ||
| >110 (26) | NS | <.05 |
Abbreviation: NS, not significant.